The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Nektar Therapeutics

Nasdaq: NKTR
Last

(U.S.) $71.59

Today's change+1.43 +2.04%
Updated January 19 4:00 PM EST. Delayed by at least 15 minutes.
 

Nektar Therapeutics

Nasdaq: NKTR
Last

(U.S.) $71.59

Today's change+1.43 +2.04%
Updated January 19 4:00 PM EST. Delayed by at least 15 minutes.

Nektar Therapeutics up sharply

Nektar Therapeutics closed up sharply Friday, rallying (U.S.)$1.43 or 2.04% to (U.S.)$71.59. Shares have lost 0.57% for the last five days, but sit just 4.96% below their 52-week high. This security has outperformed the S&P 500 by 460.26% during the last year.

Key company metrics

  • Open(U.S.) $69.75
  • Previous close(U.S.) $70.16
  • High(U.S.) $72.18
  • Low(U.S.) $69.62
  • Bid / Ask(U.S.) $56.00 / (U.S.) $71.49
  • YTD % change+19.88%
  • Volume3,699,340
  • Average volume (10-day)2,951,285
  • Average volume (1-month)2,268,792
  • Average volume (3-month)2,177,200
  • 52-week range(U.S.) $11.41 to (U.S.) $75.33
  • Beta1.82
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.71
Updated January 19 4:00 PM EST. Delayed by at least 15 minutes.

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2017Q2/2017Q1/2017Q4/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201709/30/2017Jun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016
Revenue153352537
Total other revenue--------
Total revenue153352537
Gross profit147261931
Total cost of revenue6967
Total operating expense83857970
Selling / general / administrative12161213
Research & development66606150
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)------0
Other operating expenses, total--------
Operating income69-51-54-32
Interest income (expense), net non-operating-10-10-10-10
Gain (loss) on sale of assets--------
Other--------
Income before tax61-60-64-42
Income after tax61-60-64-42
Income tax, total0000
Net income61-60-64-42
Total adjustments to net income--------
Net income before extra. items61-60-64-42
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items61-60-64-42
Inc. avail. to common incl. extra. items61-60-64-42
Diluted net income61-60-64-42
Dilution adjustment--------
Diluted weighted average shares163155154149
Diluted EPS excluding extraordinary itemsvalue per share0.37-0.39-0.42-0.28
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share0.37-0.39-0.42-0.28